External site

By following this link, you are leaving Medically and entering a website that is not owned or controlled by Roche. Roche does not take any responsibility for access to or use of this website, nor for any content therein.

Leave site
Roche and Genentech at

ISPOR Europe 2025

-
Coming soon
04:00 PM
Duration 180mins Glasgow, UK
Considerations for modelling caregiver spillover within economic evaluations for neurological disorders: Spinal Muscular Atrophy (SMA), Duchenne Muscular Dystrophy (DMD) and Multiple Sclerosis (MS)
Eric Ngonga Kemadjou, C Simone Sutherland, Chui-ying Yip, Katya Galactionova

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
04:00 PM
Duration 60mins Glasgow, UK
Payer and HTA Evaluation Criteria and Considerations for Coverage and Reimbursement of Patient Self-Monitoring Technology
Malyon A

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
Duration 180mins Glasgow, UK
Significant burden of chronic obstructive pulmonary disease (COPD) on health status and well-being persists among patients experiencing one severe or two or more moderate exacerbations of COPD and their caregivers
Denise M Boudreau, Johannes Ammann, Joanna de Courcy, Jacob Devine, Paul Hernandez, Claudio Micheletto, Jennifer Quint, Katerina Samara, Tonya Winders, Per-Olof Thuresson

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
Duration 180mins Glasgow, UK
Long-Term Economic Impact of Non-Persistence to Disease Modifying Therapies in a Cohort of German Patients with Multiple Sclerosis
Braune, Stefan; Bergmann, Arnfin; Heer, Yanic; Bianca Jarecki, Jana; Muros-Le Rouzic, Erwan; Sun, Diana; Athanasios, Siadimas

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
07:00 AM
Duration 60mins Glasgow, UK
Optimizing MASLD Diagnostic Protocols: A Microsimulation Analysis of Test Sensitivity Requirements
Garay OU

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
Duration 60mins Glasgow, UK
Budget Impact Analysis of Introducing the Elecsys® PRO-C3 assay as part of the ADAPT Algorithm for Assessing the Severity of Hepatic Fibrosis in Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) in the UK
Garay OU

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
Duration 60mins Glasgow, UK
Cost-Effectiveness Analysis of GAAD Algorithm for Hepatocellular Carcinoma Surveillance of Cirrhotic Patients using Italian Real-World Data
Porta C

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
Duration 60mins Glasgow, UK
Budget Impact of Introducing Accu-Chek SmartGuide Real-Time Continuous Glucose Monitoring (rtCGM) solution for Diabetes Management in Portugal
Torres J

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
Duration 60mins Glasgow, UK
Cross-validation of the glycated haemoglobin (HbA1c) Translator: a predictive tool to evaluate the relationship between diabetes complications and associated healthcare costs
Garay OU

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
Duration 60mins Glasgow, UK
Procalcitonin-Guided Antimicrobial Stewardship for Sepsis and Lower Respiratory Tract Infections: A Budget Impact Analysis for the Perspective of the Patients in India
Angadi E

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
09:00 AM
Duration 150mins Glasgow, UK
Reducing the transmission and annual burden of influenza in the UK with baloxavir marboxil▼: A cost-effectiveness analysis using evidence from the CENTERSTONE trial
Kommandantvold SA

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar